FR2301266A1 - Procede de preparation de gamma-globulines injectable par voie intraveineuse a - Google Patents

Procede de preparation de gamma-globulines injectable par voie intraveineuse a

Info

Publication number
FR2301266A1
FR2301266A1 FR7604333A FR7604333A FR2301266A1 FR 2301266 A1 FR2301266 A1 FR 2301266A1 FR 7604333 A FR7604333 A FR 7604333A FR 7604333 A FR7604333 A FR 7604333A FR 2301266 A1 FR2301266 A1 FR 2301266A1
Authority
FR
France
Prior art keywords
globulins
injection
intravenous use
preparing gamma
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7604333A
Other languages
English (en)
Other versions
FR2301266B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COVAL MYER
Original Assignee
COVAL MYER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COVAL MYER filed Critical COVAL MYER
Publication of FR2301266A1 publication Critical patent/FR2301266A1/fr
Application granted granted Critical
Publication of FR2301266B1 publication Critical patent/FR2301266B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7604333A 1975-02-18 1976-02-17 Procede de preparation de gamma-globulines injectable par voie intraveineuse a Granted FR2301266A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55046775A 1975-02-18 1975-02-18

Publications (2)

Publication Number Publication Date
FR2301266A1 true FR2301266A1 (fr) 1976-09-17
FR2301266B1 FR2301266B1 (fr) 1979-10-05

Family

ID=24197306

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7604333A Granted FR2301266A1 (fr) 1975-02-18 1976-02-17 Procede de preparation de gamma-globulines injectable par voie intraveineuse a

Country Status (4)

Country Link
US (1) US4093606A (fr)
CA (1) CA1064396A (fr)
DE (1) DE2606118C2 (fr)
FR (1) FR2301266A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092186A2 (fr) * 1982-04-16 1983-10-26 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Méthode de préparation de gamma-globuline convenant à l'administration intraveineuse
EP0106608A2 (fr) * 1982-10-07 1984-04-25 Green Cross Corporation Procédé pour lyophiliser la globuline insoluble au froid
WO1986006963A1 (fr) * 1985-05-30 1986-12-04 Institut Merieux Procede de preparation de gamma-globulines administrees par voie intraveineuse et gamma-globulines obtenues
EP0270025A3 (en) * 1986-12-02 1989-05-10 Schwab & Co. Ges.M.B.H. Process for the preparation of an intravenously administrable immunoglobulin stable in the liquid phase
WO1997049732A1 (fr) * 1996-06-27 1997-12-31 Dox-Al Italia S.P.A. IMMUNOGLOBULINES IgG ET LEURS FRAGMENTS F(ab')2 SPECIFIQUES POUR DES MEDICAMENTS ET LEURS METABOLITES, ET LEUR UTILISATION A DESFINS DE DETOXIFICATION

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4272521A (en) 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
US4374763A (en) * 1979-09-17 1983-02-22 Morishita Pharmaceutical Co., Ltd. Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
JPS57206608A (en) 1981-05-29 1982-12-18 Mochida Pharmaceut Co Ltd Production of gamma-globulin for intravenous injection
JPS591691B2 (ja) * 1981-05-29 1984-01-13 株式会社ミドリ十字 静注用γ−グロブリン製剤
JPS57203017A (en) * 1981-06-09 1982-12-13 Fujirebio Inc Purifying method of immunoglobulin
JPS5821623A (ja) * 1981-07-28 1983-02-08 Tetsuzo Sugizaki 抗原抗体複合体沈着疾患治療剤
US4499073A (en) * 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4465670A (en) * 1982-07-23 1984-08-14 Dainippon Pharmaceutical Co., Ltd. Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor
EP0116571B2 (fr) * 1982-08-30 1997-10-29 BAXTER INTERNATIONAL INC. (a Delaware corporation) Procede de fabrication de compositions contenant de la gamma globuline
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
US4597966A (en) * 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
AT389817B (de) * 1987-01-22 1990-02-12 Schwab & Co Ges Mbh Verfahren zur herstellung eines in fluessiger form stabilen immunglobulins zur intravenoesen anwendung
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals
US5525519A (en) * 1992-01-07 1996-06-11 Middlesex Sciences, Inc. Method for isolating biomolecules from a biological sample with linear polymers
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
CA2232420A1 (fr) * 1997-03-19 1998-09-19 The Green Cross Corporation Preparation d'immunoglobuline et processus de production
AU6914998A (en) 1997-04-07 1998-10-30 Cangene Corporation Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
US7541020B2 (en) * 1997-05-08 2009-06-02 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
WO2000066160A1 (fr) * 1999-04-28 2000-11-09 Yamanouchi Pharmaceutical Co., Ltd. Composition medicamenteuse parenterale a fragment d'anticorps monoclonal humanise et procede de stabilisation
US20020098182A1 (en) * 2000-09-28 2002-07-25 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
WO2002030463A2 (fr) * 2000-10-12 2002-04-18 Genentech, Inc. Formulations de proteine concentrees a viscosite reduite
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US20040180045A1 (en) * 2001-09-28 2004-09-16 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
US20050158303A1 (en) * 2003-04-04 2005-07-21 Genentech, Inc. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
EP1610820B2 (fr) 2003-04-04 2013-08-21 Genentech, Inc. Preparations d'anticorps et de proteines a forte concentration
WO2006023831A2 (fr) 2004-08-20 2006-03-02 Prometic Biosciences Ltd. Mecanismes d'isolement et de purification sequentiels de proteines par chromatographie d'affinite
WO2007008697A2 (fr) * 2005-07-08 2007-01-18 University Of Chicago Compositions et methodes pour le repliement de proteines denaturees
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
TWI532498B (zh) 2008-03-17 2016-05-11 巴克斯特保健公司 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
MX2011009306A (es) * 2009-03-06 2011-10-13 Genentech Inc Formulacion con anticuerpo.
AU2010296017C1 (en) 2009-09-17 2013-09-19 Takeda Pharmaceutical Company Limited Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
WO2011109452A1 (fr) 2010-03-01 2011-09-09 Bayer Healthcare Llc Optimisation d'anticorps monoclonaux dirigés contre l'inhibiteur de la voie du facteur tissulaire (tfpi)
ES2381828B1 (es) 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437060A (en) * 1945-10-23 1948-03-02 Nasa Process of recovering gamma globulins from human blood serum
DK79841C (da) * 1952-08-04 1955-09-12 Behringwerke Ag Fremgangsmåde til fremstilling af stabile γ-globulinpræparater.
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
NL286954A (fr) * 1962-01-03
GB1198277A (en) * 1967-09-05 1970-07-08 Ustav Ser A Ockovacich Latek O Process for the Preparation of Serum Gamma Globulins by Fractionation of Blood Serum, Plasma or Raw Serum Fractions with Quaternary Ammonium Compounds
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4000121A (en) * 1973-01-30 1976-12-28 Baxter Travenol Laboratories, Inc. Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US3880989A (en) * 1973-01-30 1975-04-29 Baxter Laboratories Inc Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
DE2353973C3 (de) * 1973-10-27 1979-10-04 Behringwerke Ag, 3550 Marburg Steroid-bindendes Globulin und Verfahren zu dessen Herstellung
CA1007568A (en) * 1973-12-13 1977-03-29 Michael C. Attwell Bovine immunoglobulin isolation process
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
DE2364792A1 (de) * 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092186A2 (fr) * 1982-04-16 1983-10-26 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Méthode de préparation de gamma-globuline convenant à l'administration intraveineuse
EP0092186A3 (en) * 1982-04-16 1984-07-18 Fujirebio Kabushiki Kaisha Also Trading As Fujirebio Inc. Method of preparing gamma globulin suitable for intravenous administration
EP0106608A2 (fr) * 1982-10-07 1984-04-25 Green Cross Corporation Procédé pour lyophiliser la globuline insoluble au froid
EP0106608A3 (en) * 1982-10-07 1986-03-26 The Green Cross Corporation Method of lyophilizing cold insoluble globulin
WO1986006963A1 (fr) * 1985-05-30 1986-12-04 Institut Merieux Procede de preparation de gamma-globulines administrees par voie intraveineuse et gamma-globulines obtenues
FR2582515A1 (fr) * 1985-05-30 1986-12-05 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
EP0270025A3 (en) * 1986-12-02 1989-05-10 Schwab & Co. Ges.M.B.H. Process for the preparation of an intravenously administrable immunoglobulin stable in the liquid phase
US4880913A (en) * 1986-12-02 1989-11-14 Schwab & Co. Ges.M.B.H. Process for the preparation of an immunoglobulin which can be administered intravenously and is stable in liquid form
WO1997049732A1 (fr) * 1996-06-27 1997-12-31 Dox-Al Italia S.P.A. IMMUNOGLOBULINES IgG ET LEURS FRAGMENTS F(ab')2 SPECIFIQUES POUR DES MEDICAMENTS ET LEURS METABOLITES, ET LEUR UTILISATION A DESFINS DE DETOXIFICATION

Also Published As

Publication number Publication date
DE2606118C2 (de) 1982-11-18
US4093606A (en) 1978-06-06
CA1064396A (fr) 1979-10-16
DE2606118A1 (de) 1976-08-26
FR2301266B1 (fr) 1979-10-05

Similar Documents

Publication Publication Date Title
FR2301266A1 (fr) Procede de preparation de gamma-globulines injectable par voie intraveineuse a
FR2297707A1 (fr) Procede perfectionne pour le moulage de pieces creuses par injection
FR2301505A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
BE844575A (fr) Procede de preparation de dinitriles insatures
BE781462A (fr) Procede de preparation d'acides 1-aminoalcane-1,1-diphosphoniques
FR2302379A1 (fr) Procede de preparation de
FR2316224A1 (fr) Procede de preparation de l-aminoacides soufres
FR2322153A1 (fr) Procede de preparation de triarylphosphines
BE824269A (fr) Procede de preparation de polymeres modifies par des lactones
BE839252A (fr) Procede de preparation de benz alpha -2,5-oxazocines
FR2306192A1 (fr) Procede de preparation d'acides arylpropioniques
BE839004A (fr) Procede de preparation de 4-oxo-hexahydropyrazino-isoquinoleine
FR2329625A1 (fr) Procede de preparation de trichloromethyltrifluoromethylbenzene
FR2325656A1 (fr) Procede de preparation de chlorophosphites
FR2298614A1 (fr) Procede de preparation de n-(a-alcoxyethyl)-carboxamides
FR2333805A1 (fr) Procede de preparation de n,n'-bis-trimethylsilyluree
BE847214A (fr) Procede de preparation de trimethyldroquinone,
BR7409968A (pt) Agulha de fazer malha aperfeicoada
RO68473A (fr) Procede pour la preparation d'un catalyseur de polymerisation
BE843910A (fr) Procede de preparation de 2,5-dioxo-1-oxa-2-phospholanes
BE825567A (fr) Procede de preparation d'acides 5-sulfamoyl-anthraniliques
FR2335538A1 (fr) Procede de preparation de copolymeres sequences
FR2322152B1 (fr) Procede de preparation d'acides epoxyalkylphosphoniques
BE837753A (fr) Procede de preparation de sulfonylurees
FR2305432A1 (fr) Procede de preparation de 3,5-dialcoyl-4-mercapto-phenol

Legal Events

Date Code Title Description
ST Notification of lapse